Letter regarding levosimendan in a rat model of severe verapamil poisoning

Abraham MK, Scott SB, Meltzer A, et al. Levosimendan does not improve survival time in a rat model of verapamil toxi- city.J Med Toxicol 2009;5(1):3–7. Graudins A, Najafi JM, Perry M. Treatment of experimen- tal verapamil poisoning with levosimendan utilizing a rodent model of drug toxicity.Clin Toxicol 2008;46(1):50–56. Ka Ling K, Graudins A. Treatment of experimental verapamil poisoning with levosimendan and 4-aminopyridine (abstract).Clin Toxicol 2008;46(7):593. Najafi JM, Graudins A. Norepinephrine co-administered with levosimendan does not reverse hypotension in a rodent model experimental verapamil poisoning (abstract).Emerg Med Australas 2007;19(Suppl1):A19-A20. Hohn J, Pataricza J, Petri A, et al. Levosimendan interacts with potassium channel blockers in human saphenous veins.Basic Clin Pharmacol Toxicol 2004;94(6):271–273. Huang L, Weil MH, Tang W, et al. Comparison between dobutamine and levosimendan for management of postresusci- tation myocardial dysfunction.Crit Care Med 2005;33(3): 487–491.